The only thing I’ve ever been asked by a doctor is, am I having sex or am I not having sex? And whatever answer I gave always seemed like the wrong answer.” The Pink Pill examines just how persistent that disinterest in female sexuality, beyond reproduction, runs throughout the US medical establishment.
Women finally have a new option for their sagging desire. Pre-menopausal women with low sexual desire don’t have to be distressed about their reduced desire. The diagnosis of female Hypoactive Sexual Desire Disorder “HSDD” needs a thorough evaluation and conversation between you and your doctor and can be treated. Several factors can contribute to a low sex drive. Painful sexual activity (from vaginismus, vaginal atrophy, skin disorders like lichen sclerosis) Pelvic surgeries like having your uterus or ovaries removed When these conditions have resolved or been treated and a woman is in love with her partner and still has absent or markedly reduced desire, it is time to determine if you have HSDD.
It’s no surprise that studies show women with sexual dysfunction may be more associated with lower positive feelings of physical, emotional and overall happiness in life and thus can have a big impact of a woman’s quality of life. It is important to take charge and do something about it. We have been trying to deal with HSDD in the past with off-label use of medications like testosterone, estrogen, anti-depressant use such as wellbutrin (bupropion that may help with climax) and other lifestyle regimens like psychotherapy and sexual counseling. Viagra was approved for men in 1998 and now after 17 years, women have a drug which has gone through extensive study and received historic approval from FDA after the third try. Flibanserin tends to increase the activity of certain neurochemicals in the brain and inhibits serotonin in the brain and shows improvement in female sexual desire. As several sexual health doctors, gynecologists and urologists attest, most medical school curricula do not include sections on female sexual health, viagra click and collect libido or clitoral anatomy. When Viagra was introduced in 1998, the medical establishment quickly adopted a drug that was seen as a breakthrough treatment for a physical issue in men.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 150mg | 10 Pills | 36.73€ 34.98€ | |
| Viagra Generic | 100mg | 360 + 10 Pills | 330.21€ 314.49€ | |
| Viagra Generic | 200mg | 20 Pills | 61.69€ 58.75€ | |
| Viagra Generic | 25mg | 270 + 8 Pills | 184.26€ 175.49€ | |
| Viagra Generic | 150mg | 180 + 10 Pills | 236.46€ 225.20€ | |
| Viagra Generic | 25mg | 30 + 4 Pills | 47.97€ 45.69€ | |
| Viagra Generic | 25mg | 120 + 6 Pills | 125.56€ 119.58€ | |
| Viagra Oral Jelly | 100mg | 10 Sachets | 46.36€ 44.15€ | |
| Viagra Super Active | 100mg | 20 + 4 Pills | 48.05€ 45.76€ | |
| Viagra Generic | 150mg | 60 + 4 Pills | 111.25€ 105.95€ | |
| Viagra Soft Tabs | 100mg | 20 Pills | 62.99€ 59.99€ | |
| Viagra Professional | 100mg | 270 + 6 Pills | 456.97€ 435.21€ | |
| Viagra Original | 100mg | 8 Pills | 59.84€ 56.99€ | |
| Viagra Original | 100mg | 92 + 4 Pills | 362.88€ 345.60€ | |
| Viagra Generic | 50mg | 60 + 4 Pills | 83.93€ 79.93€ | |
| Viagra Original | 100mg | 48 + 4 Pills | 207.15€ 197.29€ | |
| Viagra Soft Tabs | 100mg | 180 + 10 Pills | 314.95€ 299.95€ |
But the conversation around female libido and orgasm remained stagnant, often starting and ending with “it’s complicated”. Frustration with this apathy and her own disappeared desire led Cindy Eckert, a pharmaceutical entrepreneur based in Raleigh, North Carolina, to buy flibanserin for $5m in 2011, after Boehringer Ingelheim decided not to fight for FDA approval.
It was noted that the number of “sexually satisfying encounters” increased by about one per month, from a median of 2-3 to 2.5-4. Though it’s a great achievement and opens the doors for more options for women, Flibanserin might not be for everyone. Sudden drop in blood pressure leading up to fainting Certain conditions may be best avoided when taking Flibanserin as the side effects could be profound. People who are heavy consumers of alcohol Women on certain antifungals medications for yeast infections So reduce or stop alcohol, monitor your diet, exercise to better control your blood pressure and talk to your women’s health physician to see viagra medicine if you are a candidate for Addyi®. And get ready to enjoy a better phase in life.
It’s your time and you need to take charge, enjoy your intimate life, stay healthy and be strong! -Manisha Yadav, MDSanta Clara Valley Medical Center, CA Barbara Gattuso had been happily married for decades when she signed up, in the late 2000s, for a clinical trial involving a potentially revolutionary new drug. She and her husband had once had a fulfilling sex life, both pre- and post-children. But at some point during her perimenopausal years, her desire disappeared. It wasn’t stress, fatigue or relationship issues, though her lack of libido certainly contributed to those. A hyper-feminine, distinctly 2010s entrepreneur with a fondness for everything magenta, Eckert renamed the drug Addyi after Dr Addison Grey, Kate Walsh’s character on the popular medical drama Grey’s Anatomy who represented the drug’s ethos of, as she says, “women living life on their own terms”. Her company, Sprout Pharmaceuticals, completed the necessary trials, demonstrating that Addyi improved the sexual drive and experiences of women struggling with HSDD.
By October 2013, it was ready to go to market, subject to FDA approval. Though Addyi works on neurotransmitters in the brain, akin to an antidepressant, the FDA assigned its review to its urology division – a better fit for Viagra, which relaxes muscles and increases blood flow to the male genitalia. The FDA rejected it, claiming that the side effects – namely dizziness, nausea, fatigue and low blood pressure – did not outweigh the benefits. The question of side effects – essentially, why would desire be worth it for women?
| Effect | Description | Duration | Notes |
|---|---|---|---|
| Increased Blood Flow | Eases erectile dysfunction | 4-6 hours | Primary intended effect |
| Visual Disturbances | Bluish tint, blurred vision | Transient | Rare side effect |
| Headache | Throbbing headache | Usually short | Common side effect |
| Flushing | Warm sensation on face and neck | Short-term | Common, mild side effect |
| Dizziness | Lightheadedness | Transient | Use caution when standing |
– continued to dog the medication as it sought regulatory.
The Pink Pill amasses a significant recent history archive of the “female Viagra’s” role in the culture wars of the 2010s, as Sprout mounted an aggressive lobbying campaign ahead of its 2015 hearing. Some of the backlash was predictably patronizing: “You might know [flibanserin] by its old name – wine,” joked Jimmy Fallon on The Tonight Show. Some was more grounded, such as pushback from those who believed HSDD to be a fictional condition to guilt women for their lack of sex drive, low libido medicalized in the name of pharmaceutical profit, with no medical consensus on what constitutes “normal” sexual desire. The FDA questioned the potential for sedative effects, wondering if “a woman might take flibanserin the night before and get up the next morning and fall asleep taking her kids to school”, recalls Dr Anita Clayton, a University of Virginia psychiatrist and consultant to Addyi, in the film. “There was a very paternalistic attitude.” Data showing an increase of one “successful sexual event” per month was dismissed as ineffective – even though women with untreated HSDD experienced maybe one or two such events a year.
“Women with distressing sexual desire problems need good treatments,” Schwartz and Woloshin wrote. But, they added, “we all need a drug approval process that delivers good decisions based on adequate evidence.” See more of our top stories on Facebook >> The new research -- and Schwartz and Woloshin’s commentary -- suggests that flibanserin’s fitful progress through the FDA’s approval process was driven by research that was light on detail, erected shifting goalposts, and was more likely to be published when the drug’s effectiveness was greater. A study that set out to test whether flibanserin and alcohol could be safely mixed was conducted on men -- and even then, even a modest amount of alcohol led in many cases to dizziness and low blood pressure. Post-marketing studies required by the FDA at the time it approved flibanserin won’t be done for between a year and 2 1/2 years. Follow me on Twitter @LATMelissaHealy and “like” Los Angeles Times Science & Health on Facebook.
Are climate-change adaptations tied to protecting property or people? Zika’s link to Guillain-Barre syndrome revealed A view of the Milky Way like you’ve never seen before The first ever FDA approved medication for Hypoactive Sexual Desire Disorder (HSDD) is now finally a reality. Officially known as Flibanserin or Addyi®, it has been also been called the "Pink Viagra" by lay commentators. Many women suffer with low sexual desire, which can cause significant distress. Many women want to be more engaged and be able to enjoy sexual activity rather than just going through the motions. The bias showing through the FDA approval process boiled down to “well, we just don’t know if [Addyi] is necessary’”, said Chin-Yee.
It was more like a mysterious evaporation – like “somebody pulled the plug”, as she recalls in a new documentary on flibanserin, the experimental drug that proffered potential relief. Originally developed as an anti-depressant by the German company Boehringer Ingelheim, flibanserin had instead shown promise as a treatment for low female libido, working on neurotransmitters in the so-called “sex center” of the brain. In a video from that trial filmed by Dr Irwin Goldstein, the “godfather of sexual medicine” and a key consultant on Viagra – that revolutionary blue pill for men with erectile dysfunction – Gattuso appears nearly giddy. She was chasing her husband around again, she said. She felt “phenomenal”, like a “new woman on this drug”.
It is shocking how quaint this footage looks and feels now, as it seems like this should have been an obvious breakthrough with cascading results. But as the Paramount+ documentary The Pink Pill: Sex, Drugs & Who Has Control demonstrates, the road to get flibanserin – often called, somewhat derisively, “the female Viagra” – to women struggling with their libido was anything but obvious, strewn with regulatory roadblocks, pharmaceutical price-gouging, sexist double standards and a profound societal disinterest in female choice, pleasure and experience. Though the US Food and Drug Administration (FDA) approved flibanserin, sold under the name Addyi, for premenopausal women suffering from Hypoactive Sexual Desire Disorder (HSDD) back in August 2015 (and, as of last December, for women post menopause) most women are not aware that a drug for female sexual desire exists, let alone that it’s available. Until she was approached about making the film, “I had never heard of this drug,” Aisling Chin-Yee, the director, said. “I had never even thought about going in and talking to my doctor about my sex life. “But that’s not a question that has ever come up when it comes to male sexual dysfunction.
It is absolutely imperative that if you are a man with a penis, you should be able to do whatever you want with it. And those were not the same considerations for women.” (The FDA, which denied any accusations of gender bias, did not respond to the film-makers’ interview requests.